Eur Rev Med Pharmacol Sci 2026; 30 (4): 126-126
DOI: 10.26355/eurrev_202604_37746

Retraction Note: Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study

S. Gerli, F. Bavetta, G.C. Di Renzo

Department of Obstetrics and Gynecology, University of Perugia, Perugia, Italy


The article “Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study” by S. Gerli, F. Bavetta, G.C. Di Renzo, published in European Review for Medical and Pharmacological Sciences 2012; 16: 1994–1998–PMID: 23242728, has been retracted by the Publisher and the Editor in Chief.

Following concerns raised by a whistleblower regarding the statistical analysis and the reliability of the reported results, the journal initiated an editorial investigation in accordance with ethical policies.

The authors were contacted and provided a response. An independent statistical expert was also appointed to reassess the methodology and data analysis.

The evaluation identified significant methodological and statistical concerns that affect the validity and interpretation of the study findings.

In light of these issues, the Editor-in-Chief has concluded that the reliability of the results and the conclusions of the article are compromised. The article is therefore retracted.

This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
Free PDF Download

To cite this article

S. Gerli, F. Bavetta, G.C. Di Renzo
Retraction Note: Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study

Eur Rev Med Pharmacol Sci
Year: 2026
Vol. 30 - N. 4
Pages: 126-126
DOI: 10.26355/eurrev_202604_37746

Publication History

Published online: 30 Apr 2026